NCT00004682 2015-03-25
Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
FDA Office of Orphan Products Development
Phase NA Terminated
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development